Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 56 (0%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 825 (-2.9%)CIAL ₹ 444 (1.4%)CSK ₹ 254 (-3.8%)ESDS Software₹ 482 (7.6%)Hinduja Leyland₹ 244 (-1.6%)ICL Fincorp₹ 25 (0%)India Carbon₹ 895 (0%)Indian Potash₹ 2750 (-3.5%)Inox Clean₹ 725 (0%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 14 (-6.7%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (1.6%)NCDEX ₹ 368 (-4.2%)NSE ₹ 1985 (-2.9%)Onix Renewable₹ 66 (11.9%)OYO ₹ 24 (0%)OYO Assets₹ 9.25 (-22.9%)Pharmeasy ₹ 6.25 (0%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-9.7%)RRP S4E₹ 158 (-6%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)Ticker Ltd₹ 32 (0%)Zepto ₹ 42 (-12.5%)

15 Days Price Change

Innova Captab IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2005 Industry: Pharmaceuticals & Drugs Listed Page

Profile
Issue Size --
Profile
Price Range 426  to  448 per share
Profile
Min Investment ₹448
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Innova Captab Ltd is a dynamic pharmaceutical company committed to advancing healthcare through innovation and excellence. Specializing in the development, manufacturing, and marketing of high-quality pharmaceutical products, Innova Captab is dedicated to meeting the diverse healthcare needs of patients worldwide. With a focus on research and development, the company strives to introduce cutting-edge solutions and novel formulations to address prevalent medical challenges. Innova Captab's state-of-the-art facilities and adherence to stringent quality standards underscore its commitment to delivering safe and effective healthcare solutions. As a customer-centric organization, Innova Captab aims to contribute significantly to the global pharmaceutical landscape by providing reliable, affordable, and innovative healthcare solutions for a healthier future. Read More

Basic Info

Face Value 10 per share

Price 426  to  448 per share

P/E (x) 20

Sales( Cr.) 1244

PAT( Cr.) 128

EPS 22.4

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Manoj Kumar Lohariwala Vinay Kumar Lohariwala

Pre Issue Share Holding 70.75%

Post Issue Share Holding 50.45%

Listing Details:

Listing Price: 456.1

Listing Gain: 1.78%

Current Price: 848.3

Gain On Issue: 848.3 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Dec 21, 2023
Closing Date Dec 26, 2023
Allotment Dec 27, 2023
Refund Dec 28, 2023
Delivery of Shares Dec 28, 2023
Listing Date Dec 29, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 33 14,784
Retail (Max) 13 429 192,192
S-HNI (Min) 14 462 206,976
S-HNI (Max) 67 2211 990,528
B-HNI (Min) 68 2244 1,005,312

Objective of the Issue

1. Repayment and / or prepayment in part or in full, of certain outstanding loans of the Company 2. Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML 3. Funding the working capital requirements 4. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 6361607 742590385 116.7x
NII 1908482 123955906 65x
Retail 4453125 76371094 17.2x
EMP 0 0 0x
Total 12723214 703084806 55.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Innova Captab Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 356 373 411 801 926 1081 1244
Other Income 0 1 1 3 9 12 12
Total Income 356 375 412 803 936 1094 1256
Total Expenditure 315 322 356 705 813 927 1058
Operating Profit 41 52 56 99 123 167 198
Interest 6 5 4 6 20 21 2
Depreciation 11 10 6 8 11 16 25
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax 25 38 46 86 92 130 171
Provision for Tax 5 10 12 22 24 35 43
Profit After Tax 20 28 35 64 68 94 128
Adjustments 0 -0 -0 -0 0 0 0
Profit After Adjustments 20 28 34 64 68 94 128
Adjusted Earnings Per Share 4.2 5.8 7.2 13.3 14.2 16.5 22.4

Innova Captab Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 82 110 145 209 277 831 959
Minority's Interest 0 0 0 0 0 0 0
Borrowings 26 12 6 67 134 208 244
Other Non-Current Liabilities 2 3 38 21 60 -4 12
Total Current Liabilities 117 129 215 315 278 294 376
Total Liabilities 228 254 404 612 748 1329 1592
Fixed Assets 78 73 79 183 183 358 830
Other Non-Current Assets 1 1 55 29 123 363 35
Total Current Assets 148 180 270 400 442 608 719
Total Assets 228 254 404 612 748 1329 1592

Innova Captab Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 2 5 0 4 12
Cash Flow from Operating Activities 19 31 42 59 67 146 64
Cash Flow from Investing Activities -9 -6 -20 -188 -91 -499 -152
Cash Flow from Financing Activities -9 -23 -19 125 27 361 92
Net Cash Inflow / Outflow 1 1 3 -5 3 8 4
Closing Cash & Cash Equivalent 1 2 5 0 4 12 16

Innova Captab Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.15 5.81 7.17 13.29 14.16 16.49 22.41
CEPS(Rs) 6.36 7.91 8.35 14.89 16.46 19.28 26.74
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) 17.18 22.99 30.17 43.46 57.61 145.2 167.66
Core EBITDA Margin(%) 11.46 13.62 13.24 11.88 12.09 14.25 14.71
EBIT Margin(%) 8.52 11.27 12.21 11.31 11.89 13.93 13.7
Pre Tax Margin(%) 6.96 10.03 11.26 10.6 9.76 11.95 13.51
PAT Margin (%) 5.58 7.46 8.38 7.91 7.23 8.71 10.13
Cash Profit Margin (%) 8.58 10.15 9.74 8.84 8.41 10.18 12.09
ROA(%) 8.72 11.57 10.48 12.58 9.99 9.08 8.78
ROE(%) 24.1 28.92 27.04 36.19 28.02 17.04 14.33
ROCE(%) 19.63 26.48 28.42 30.64 24.34 19.06 14.65
Receivable days 93.14 86.65 99.91 79.3 92.78 93.25 89.43
Inventory Days 39.71 50.85 69.58 49.63 47.7 44.01 50.76
Payable days 101.39 108.78 122.96 88.6 100.16 106.52 108.88
PER(x) 0 0 0 0 0 27.18 39.15
Price/Book(x) 0 0 0 0 0 3.09 5.23
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) 0.23 0.16 0.11 0.26 0.29 2.52 4.25
EV/Core EBITDA(x) 2.01 1.16 0.81 2.1 2.15 16.29 26.69
Net Sales Growth(%) 0 4.92 10 94.94 15.72 16.72 15.02
EBIT Growth(%) 0 38.95 19.25 81.81 22.28 35.09 14.86
PAT Growth(%) 0 40.3 23.72 85.37 6.26 38.84 35.95
EPS Growth(%) 0 39.89 23.53 85.3 6.54 16.46 35.95
Debt/Equity(x) 0.87 0.48 0.31 0.95 0.85 0.29 0.35
Current Ratio(x) 1.26 1.39 1.26 1.27 1.59 2.07 1.91
Quick Ratio(x) 0.93 0.89 0.83 0.86 1.17 1.58 1.36
Interest Cover(x) 5.44 9.11 12.8 16.09 5.6 7.04 72.11
Total Debt/Mcap(x) 0 0 0 0 0 0.09 0.07

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 15% 16% 27% 0%
Operating Profit CAGR 19% 26% 31% 0%
PAT CAGR 36% 26% 36% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -2% NA% NA% NA%
ROE Average 14% 20% 25% 25%
ROCE Average 15% 19% 23% 23%

Company Contact Information

Innova Captab Ltd.

1513, 15th Floor, Satra Plaza Chs Ltd. Plot No. 19 & 20 Sector-19 D Vashi

IPO Lead Manager(s)

Innova Captab Ltd.

ICICI Securities Ltd

JM Financial Ltd.

Registrar Info

Innova Captab Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!